Hydrocarbon toxicity: Difference between revisions
Kghaffarian (talk | contribs) (capitalizations) |
Kghaffarian (talk | contribs) |
||
| Line 45: | Line 45: | ||
* Beta2 agonist if wheezing (not proven benefit), consider Bipap/Cpap (may further barotrauma) | * Beta2 agonist if wheezing (not proven benefit), consider Bipap/Cpap (may further barotrauma) | ||
* Severe toxicity will need intubation, high PEEP, possibly high frequency jet ventilation, and ECMO for refractory hypoxemia | * Severe toxicity will need intubation, high PEEP, possibly high frequency jet ventilation, and ECMO for refractory hypoxemia | ||
* | * Antibiotic prophylaxis show no benefit, but use if superinfection present | ||
* | * Steroids not recommended for chemical pneumonitis and can lead to increased superinfection | ||
Cardiovascular<br /> | Cardiovascular<br /> | ||
* Treat hypotension w aggressive IVF | * Treat hypotension w aggressive IVF | ||
| Line 52: | Line 52: | ||
* Treat ventricular dysrhythmias with propranolol, esmolol or lidocaine | * Treat ventricular dysrhythmias with propranolol, esmolol or lidocaine | ||
Dermal<br /> | Dermal<br /> | ||
* | * Pre-arrival decontamination, remove clothing | ||
* | * Soap and water, saline for eye exposure | ||
GI<br /> | GI<br /> | ||
* GI decontamination controversial | * GI decontamination controversial | ||
Revision as of 02:35, 30 August 2015
Background
- Typical exposures:
- Unintentional exposure (generally young children)
- Intentional abuse (generally adolescents, young adults)
- Occupational exposure - dermal, inhalation
- Intentional abuse methods:
- Huffing= hydrocarbon soaked into rag and placed over mouth and nose
- Bagging= hydrocarbon placed in a bag and fumes inhaled
- Sniffing= hydrocarbon inhaled directly
- High volatility, low viscosity → high risk for aspiration despite "simple ingestion"
Examples
- Gasoline
- Lighter fluid
- Lamp oil
- Petroleum jelly (Vaseline)
- Paint
- Paint thinners
- Polish
Clinical Features
- Pulmonary: aspiration
- Risk factors: high volume, vomiting, gagging, choking, coughing
- CXR on presentation nonpredictive, but usually appear by 6hrs
- Cardiac: arrhythmias, Afib, PVCs, Vtach, torsades
- "Sudden sniffing death syndrome"= suspected cardiac sensitization to catecholamines
- Classic scenario: Sniffer is startled during use, collapses and dies
- CNS/PNS: excitation, followed by depression, ataxia, neuropathy
Differential Diagnosis
Diagnosis
- Clinical diagnosis
Workup
- CXR: immediately if symptomatic, otherwise early CXR not predictive of pneumonitis. Observe for 4-6hrs then obtain CXR
- Labs: as needed to evaluate for acidosis, anemia, renal/hepatic toxicity, coagulation, methemoglobinemia, carboxyhemoglobinemia depending on specific exposure
- ECG
Management
Pulmonary
- Secure airway, if needed.
- Beta2 agonist if wheezing (not proven benefit), consider Bipap/Cpap (may further barotrauma)
- Severe toxicity will need intubation, high PEEP, possibly high frequency jet ventilation, and ECMO for refractory hypoxemia
- Antibiotic prophylaxis show no benefit, but use if superinfection present
- Steroids not recommended for chemical pneumonitis and can lead to increased superinfection
Cardiovascular
- Treat hypotension w aggressive IVF
- Avoid dopamine, epinephrine, norepinephrine (may cause dysrhythmias)
- Treat ventricular dysrhythmias with propranolol, esmolol or lidocaine
Dermal
- Pre-arrival decontamination, remove clothing
- Soap and water, saline for eye exposure
GI
- GI decontamination controversial
- Majority do not benefit
Disposition
- Discharge after 6 hour observation if:
- Asymptomatic
- Normal vital signs (including SpO2)
- No abnormal pulmonary findings
- Normal CXR at 6hrs post exposure
- If asymptomatic but radiographic evidence of pneumonitis, consider discharge with 24-hour follow-up.
- Admit:
- Clinical evidence of toxicity
See Also
References
- Bass M. Sudden sniffing death. JAMA. 1970;212:2075-2079
- Bysani BK et al. Treatment of hydrocarbon pneumonitis: high frequency jet ventilation as an alternative to extracorporeal membrane oxygenation. Chest. 1994;106:300-303.
- Brock WJ et al. Cardiac sensitization: methadology and interpretation in risk assessment. Toxicol Pharmacol. 2003;38:78-90.
